Ask AI
ProCE Banner Events

Share

Beyond Chemotherapy: Patient Voices and Expert Insights on Using Precision Therapies to Enhance Personalized Care of Follicular Lymphoma

This 2-hour interactive live satellite symposium held conjunction with the 67th American Society of Hematology (ASH) Annual Meeting in Florida will provide expert perspectives on how to integrate and optimize the use of bispecific antibodies and CAR T-cell therapies in the treatment of patients with relapsed/refractory follicular lymphoma, including the key efficacy and safety data supporting the use of these agents, identification of eligible patients, management of the associated adverse events, and emerging therapies in the treatment of relapsed/refractory follicular lymphoma.

Friday Satellite Symposium preceding the 67th ASH Annual Meeting and Exposition. 

Physicians: maximum of 2.00 AMA PRA Category 1 Credits™

Physicians ABIM MOC: maximum of 2.00 Medical Knowledge MOC points

Who Should Attend

This activity is intended for hematologists, medical oncologists, and other healthcare professionals who care for patients with follicular lymphoma.

Time and location

Friday, December 05, 2025

7:00 AM - 9:30 AM Eastern Time (ET)

In-person

7:30 AM - 9:30 AM Eastern Time (ET)

Virtual

The Hyatt Regency Orlando
9801 International Dr
Orlando, Florida 32819

Regency R

Agenda

Registration & Breakfast: 7:00 AM - 7:30 AM ET

Symposium: 7:30 AM - 9:30 AM ET

 

Agenda

•          Patient Insights: Unmet Needs in R/R FL

•          FL in 2025: Overview and Unmet Needs With Current Management of R/R FL

•          Integrating Bispecific Antibodies Into the Treatment of Patients With R/R FL

•          Optimizing CAR T-Cell Therapies in R/R FL

•          Current and Emerging Targeted Therapies and Monoclonal Antibodies for R/R FL

•           Panel Discussions, Final Thoughts, and Audience Question and Answer Session

Location

Venue Name

The Hyatt Regency Orlando

Address

The Hyatt Regency Orlando
9801 International Dr
Orlando, Florida 32819

Room Name

Regency R

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, confidence, and competence of learners in patient-centered management of follicular lymphoma.

Target Audience
This activity is intended for hematologists, medical oncologists, and other healthcare professionals who care for patients with follicular lymphoma.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Develop communication strategies supporting patient engagement in care based on insights into the unmet needs of patients with relapsed/refractory follicular lymphoma

  • Evaluate the clinical rationale and emerging safety and efficacy evidence for novel treatments of patients with relapsed/refractory lymphoma

  • Plan chemotherapy-free treatment individualized to each patient with relapsed/refractory follicular lymphoma based on clinical evidence, expert recommendations, and patient/disease factors

  • Implement strategies supporting equitable access to novel therapies and clinical trials in underserved populations with relapsed/refractory follicular lymphoma

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and the Follicular Lymphoma Foundation. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/67167f3d10da3.png

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.com to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC in partnership with the Follicular Lymphoma Foundation

Clinical Care Options, LLC

Supporter

Supported by educational grants from AstraZeneca, Genentech, a member of the Roche Group, Incyte Corporation, Novartis Pharmaceuticals Corporation, and Regeneron Pharmaceuticals, Inc.

AstraZeneca

Genentech, a member of the Roche Group

Incyte Corporation

Novartis Pharmaceuticals Corporation

Regeneron Pharmaceuticals, Inc

Partner

Follicular Lymphoma Foundation

Follicular Lymphoma Foundation

Contact Information

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.